MCI 2026 Request for Applications (RFA)
Who can apply: Eligible scope across the full R&D spectrum from target validation and lead identification through preclinical development. Applications are reviewed for scientific rigor, translational potential, and alignment with MCI strategic priorities.
Deadline: Letters of Intent due May 30, 2026; Research Applications due August 30, 2026